Irradiation of red blood cells and anaerobic storage
A blood storage system comprising: a collection vessel for red blood cells; an oxygen or oxygen and carbon dioxide depletion device; a storage vessel for red blood cells; tubing connecting the collection vessel to the oxygen or oxygen and carbon dioxide depletion device and the oxygen or oxygen and carbon dioxide depletion device to the storage vessel; and a gamma or X-ray irradiating device is used to irradiate red blood cells stored in the vessel, storing red blood cells under anaerobic conditions.
1. A composition comprising gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells without added L-carnitine or an alkanoyl derivative, wherein said gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells are prepared by storing oxygen and carbon dioxide-depleted red blood cells for a period of time and then gamma-irradiating to form said gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells, wherein said gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells exhibit reduced potassium leakage compared to red blood cells having been conventionally stored for a period of at least 22 days.
2. The composition of claim 1 , wherein said composition comprises reduced lesions compared to a composition comprising red blood cells conventionally stored for an equivalent period of time and then gamma-irradiated.
3. The composition of claim 1 , wherein said composition comprises reduced oxidative damage compared to a composition comprising red blood cells conventionally stored for an equivalent period of time and then gamma-irradiated.
4. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells comprise less than 20% oxygen-saturation of hemoglobin (SO 2 ).
5. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells comprise reduced irradiation damage compared to red blood cells conventionally stored for an equivalent period of time and then gamma-irradiated.
6. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells comprises a partial pressure of carbon dioxide (pCO2) of less than 10 millimeter of mercury (mmHg).
7. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells comprise increased deformability compared to red blood cells conventionally stored for an equivalent period of time and then irradiated.
8. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells comprise reduced hemolysis compared to red blood cells conventionally stored for an equivalent period of time and then irradiated.
9. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells exhibit improved post-transfusion recovery compared to red blood cells conventionally stored for an equivalent period of time and then gamma-irradiated.
10. The composition of claim 9 , wherein said improved post-transfusion recovery is after 6 weeks of storage.
11. The composition of claim 1 , wherein said composition further comprises an additive solution.
12. The composition of claim 11 , wherein said additive solution is AS-3 or OFAS3.
13. The composition of claim 1 , wherein said composition is leukoreduced.
14. The composition of claim 1 , wherein said composition is free of platelets.
15. The composition of claim 1 , wherein said composition is stored within a storage vessel substantially impermeable to oxygen or both oxygen and carbon dioxide.
16. The composition of claim 15 , wherein said storage vessel comprises an inner layer compatible with blood and an outer layer substantially impermeable to oxygen or both oxygen and carbon dioxide.
17. A method of treating a patient at risk of developing transfusion-associated graft-versus-host disease (TA-GVHD), comprising providing a composition to a patient, wherein said composition comprises gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells without added L-carnitine or an alkanoyl derivative, wherein said gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells are prepared by storing oxygen and carbon dioxide-depleted red blood cells for a period of time and then gamma-irradiating to form said gamma-irradiated, oxygen and carbon dioxide depleted red blood cells, wherein said gamma-irradiated, oxygen and carbon dioxide-depleted red blood cells exhibit reduced potassium leakage compared to red blood cells having been conventionally stored for a period of at least 22 days, wherein said method reduces a risk of TA-GVHD in said patient.
18. The method of claim 17 , wherein said patient is a patient receiving chemotherapy.
19. The method of claim 17 , wherein said patient is immuno-compromised.
20. The composition of claim 1 , wherein said gamma-irradiated oxygen and carbon dioxide depleted red blood cells comprise less than 3% oxygen-saturation of hemoglobin (SO 2 ).